Source: Arquivos de Neuro-Psiquiatria. Unidade: IMT
Subjects: ESCLEROSE MÚLTIPLA, VÍRUS JC, ANTICORPOS MONOCLONAIS
ABNT
NALI, Luiz Henrique da Silva et al. Natalizumab treatment for multiple sclerosis: Updates and considerations for safer treatment in JCV positive patients. Arquivos de Neuro-Psiquiatria, v. 72, n. 12, p. 960-965, 2014Tradução . . Disponível em: https://doi.org/10.1590/0004-282X20140142. Acesso em: 25 ago. 2024.APA
Nali, L. H. da S., Moraes, L., Fink, M. C. D., Romano, C. M., Callegaro, D., & Oliveira, A. C. P. de. (2014). Natalizumab treatment for multiple sclerosis: Updates and considerations for safer treatment in JCV positive patients. Arquivos de Neuro-Psiquiatria, 72( 12), 960-965. doi:10.1590/0004-282X20140142NLM
Nali LH da S, Moraes L, Fink MCD, Romano CM, Callegaro D, Oliveira ACP de. Natalizumab treatment for multiple sclerosis: Updates and considerations for safer treatment in JCV positive patients [Internet]. Arquivos de Neuro-Psiquiatria. 2014 ; 72( 12): 960-965.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1590/0004-282X20140142Vancouver
Nali LH da S, Moraes L, Fink MCD, Romano CM, Callegaro D, Oliveira ACP de. Natalizumab treatment for multiple sclerosis: Updates and considerations for safer treatment in JCV positive patients [Internet]. Arquivos de Neuro-Psiquiatria. 2014 ; 72( 12): 960-965.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1590/0004-282X20140142